A multicenter, randomized, double-blind, placebo-controlled 52-week maintenance and an open-label extension study of the efficacy and safety of risankizumab in subjects with Crohn's disease who responded to induction treatment in M16-006 or M15-991 study M16-000
A double-blind, placebo-controlled, randomized trial to determine the safety and efficacy of EMA401 100 mg b.i.d. in reducing 24-hour average pain intensity score in patients with painful diabetic neuropathy
Etude pilote pour évaluer la sécurité et l’efficacité du comblement utilisant de la matrice modifiée, obtenue par le dispositif AmeaCell à partir de tissu adipeux autologue et destinée à du comblement de rides au niveau du visage.
Anesthetic management reform for knee prosthesis type surgeries: comparative study of different loco-regional anesthesia techniques (traditional blocks and hock blocks) and local techniques (periarticular infiltration) for the management of pain during and after surgery
Wide Area Transepithelial Sample Esophageal Biopsy combined with Computer Assisted 3-Dimensional Tissue Analysis (WATS) For the Detection of High Grade Esophageal Dysplasia and Adenocarcinoma: A Multi- Center Prospective, Randomized, Tandem Study
15-991: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Assess the Efficacy and Safety of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment